This article is a retraction of:
RETRACTED: The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA
Frontiers Editorial Office*A Retraction of the Original Research article
The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA
by Zhang L, Deng Y, Zhang Y, Liu C, Zhang S, Zhu W, Tang Y and Deng N (2020). Front. Oncol. 10:1190. doi: 10.3389/fonc.2020.01190
Following publication, concerns were raised regarding the integrity of Figures 3B and 3D. An investigation was conducted in accordance with Frontiers guidelines and the authors failed to provide a satisfactory explanation.
This retraction was approved by the Chief Editors of Frontiers in Oncology and the Editor-in-Chief of Frontiers.
Keywords:
Citation: Frontiers Editorial Office (2021) Retraction: The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA. Front. Oncol. 10:644690. doi: 10.3389/fonc.2020.644690
Received: 21 December 2020; Accepted: 21 December 2020;
Published: 15 January 2021.
Approved by: Giuseppe Giaccone, Cornell University, United States
Copyright © 2021 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org